Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikos Kostomitsopoulos

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Alternatives to Laboratory Animals : ATLA|May 25, 2026
Emerging bioethical conflicts: One Health and animal experimentationYesim Isil Ulman, Nikos Kostomitsopoulos, Samuel Camenzind, et al.
Alternatives to Laboratory Animals : ATLA|July 8, 2025
The Istanbul Workshop organised by the 'IMPROVE' COST Action Ethics Crossover GroupAugusto Vitale, Simone Pollo, Nikos Kostomitsopoulos, et al.
Molecular Therapy. Nucleic Acids|December 27, 2019
Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic ProfileKai-Wen Huang, Vikash Reebye, Katherine Czysz, et al.
Oncogene|March 8, 2018
Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancerVikash Reebye, Kai-Wen Huang, Vivian Lin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Alternatives to Laboratory Animals : ATLA|May 25, 2026
Emerging bioethical conflicts: One Health and animal experimentationYesim Isil Ulman, Nikos Kostomitsopoulos, Samuel Camenzind, et al.
Alternatives to Laboratory Animals : ATLA|July 8, 2025
The Istanbul Workshop organised by the 'IMPROVE' COST Action Ethics Crossover GroupAugusto Vitale, Simone Pollo, Nikos Kostomitsopoulos, et al.
Molecular Therapy. Nucleic Acids|December 27, 2019
Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic ProfileKai-Wen Huang, Vikash Reebye, Katherine Czysz, et al.
Oncogene|March 8, 2018
Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancerVikash Reebye, Kai-Wen Huang, Vivian Lin, et al.
Pageof 1